Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Patrick Ritschel
AddedMar 31, 2024
UpdatedMay 31, 2026
Patrick Ritschel

Patrick Ritschel

CEO, Atsena Therapeutics

CrunchbaseLinkedIn

Patrick Ritschel's Career

Atsena Therapeutics
Atsena Therapeutics

Durham, NC, US

CEO· C-Suite · Management
StrideBio
StrideBio

Durham, NC, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Patrick Ritschel's Career

Atsena Therapeutics
Atsena Therapeutics
Series B$87.6M552019Durham, NC, US
CEO· C-Suite · Management

Leadership at Atsena Therapeutics

Sarah BhagatSarah BhagatBoard Member
Jennifer WellmanJennifer WellmanBoard Member
Sanford BoyeSanford BoyeCo-Founder
Jason LettmannJason LettmannBoard Member
Jacqueline GrantJacqueline GrantBoard Member
Shannon BoyeShannon BoyeCo-Founder

Similar to Atsena Therapeutics

Capsida BiotherapeuticsCapsida BiotherapeuticsBuena Park, CA, USGene Therapyest. 2019Capsida BiotherapeuticsBuena Park, CA, US · est. 2019

Capsida: A US-based biotech firm specializing in monogenetic and sporadic CNS/non-CNS disorders.

Late Stage Private · $140M132
Apertura Gene TherapyApertura Gene TherapyNew York City, NY, USGene Therapyest. 2021Apertura Gene TherapyNew York City, NY, US · est. 2021

Apertura Gene Therapy: A biotech firm pioneering gene therapy for debilitating diseases.

Series A · $67M29
AgtcAgtcAlachua, FL, USGene Therapyest. 1999AgtcAlachua, FL, US · est. 1999

AGTC: A biotech firm conducting clinical trials for AAV-based gene therapies for rare diseases.

Public · $195.1M350
Lacerta TherapeuticsLacerta TherapeuticsAlachua, FL, USGene Therapyest. 2017Lacerta TherapeuticsAlachua, FL, US · est. 2017

Lacerta Therapeutics: A clinical-stage gene therapy firm innovating treatments for CNS and lysosomal diseases.

Series C · $30M45
StrideBio
StrideBio
Series B$97.2M762015Durham, NC, US
Co-Founder

Leadership at StrideBio

Karen HongKaren HongBoard Member
Aravind AsokanAravind AsokanCo-Founder
Raymond Camahort Ph.D.Raymond Camahort Ph.D.Board Member
Mavis AgbandjeMavis AgbandjeCo-Founder
Mark VellecaMark VellecaBoard Member
Jayson PunwaniJayson PunwaniBoard Member

Similar to StrideBio

Strm.BioStrm.BioCambridge, MA, USGene Therapyest. 2019Strm.BioCambridge, MA, US · est. 2019

STRM.BIO: Pioneering efficient, safe, and scalable gene therapy via extracellular vesicles.

Seed · $2.1M19
BridgeBio PharmaBridgeBio PharmaPalo Alto, CA, USGenetic Medicinesest. 2015BridgeBio PharmaPalo Alto, CA, US · est. 2015

Bridgebio Pharma, a US-based biotech firm, specializes in developing medicines for genetic diseases globally.

Public · $3.6B392
StrykagenStrykagenReno, NV, USDiagnostics, TherapeuticsStrykagenReno, NV, US

Strykagen: Innovating diagnostic and therapeutic tools for rare muscle diseases.

Pre-Seed · $959k5
Solid BiosciencesSolid BiosciencesCambridge, MA, USGene Therapy, Therapiesest. 2013Solid BiosciencesCambridge, MA, US · est. 2013

Solid Biosciences Inc., a US-based biotech firm, develops therapies and devices for muscular dystrophy.

Public · $441.3M87

Patrick Ritschel's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · Kakao

People Similar to Patrick Ritschel

Elisabeth LeidermanElisabeth LeidermanBoard Member · bluebird bioSteven WattSteven WattCEO · Atterx BioTherapeuticsCharles DavidsonCharles DavidsonBoard Member · Schmitt IndustriesDIMITRIOS ILIOPOULOSDIMITRIOS ILIOPOULOSCo-Founder · Dyania HealthNick KirschNick KirschFounder · atsu